Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -12.35% is 90% above its 5-year average of -123.08%, near the high end of its 5-year range (-5998.08%–24.21%).
16.98% above its 12-month average of -14.88%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -13.83%.
NET PROFIT MARGIN
-12.35%
NET PROFIT MARGIN AVG TTM
-14.88%
NET PROFIT MARGIN AVG 3Y
-27.35%
NET PROFIT MARGIN AVG 5Y
-123.08%
NET PROFIT MARGIN AVG 10Y
-316.18%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+16.98%
CURRENT VS 3Y AVG
+54.84%
CURRENT VS 5Y AVG
+89.97%
CURRENT VS 10Y AVG
+96.09%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 627 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Ardelyx, Inc.
Market Cap
$813.96M
Net Profit Margin
-12.35%
TTM Avg
-14.88%
3Y Avg
-27.35%
5Y Avg
-123.08%
Market Cap
$805.59M
Net Profit Margin
20.69%
TTM Avg
35.62%
3Y Avg
36.75%
5Y Avg
38.26%
Market Cap
$821.00M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$835.64M
Net Profit Margin
-5933.45%
TTM Avg
-505.88%
3Y Avg
-252.94%
5Y Avg
-252.94%
Market Cap
$785.44M
Net Profit Margin
-14.52%
TTM Avg
7.87%
3Y Avg
-15.98%
5Y Avg
-254.57%
Market Cap
$785.71M
Net Profit Margin
-7.58%
TTM Avg
0.29%
3Y Avg
-4.57%
5Y Avg
-4.54%
Market Cap
$837.71M
Net Profit Margin
-61.32%
TTM Avg
-78.55%
3Y Avg
-9174.62%
5Y Avg
-9174.62%
Market Cap
$770.68M
Net Profit Margin
-147.38%
TTM Avg
-372.93%
3Y Avg
-22199.44%
5Y Avg
-19748.48%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ardelyx, Inc. (ARDX) | $813.96M | -12.35% | -14.88% | -27.35% | -123.08% |
| Apnimed, Inc. (APMD)vs › | $805.62M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $805.59M | 20.69% | 35.62% | 36.75% | 38.26% |
| Jade Biosciences, Inc. (JBIO)vs › | $821.00M | 0.00% | 0.00% | 0.00% | 0.00% |
| Alumis Inc. (ALMS)vs › | $835.64M | -5933.45% | -505.88% | -252.94% | -252.94% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $785.44M | -14.52% | 7.87% | -15.98% | -254.57% |
| AdaptHealth Corp. (AHCO)vs › | $785.71M | -7.58% | 0.29% | -4.57% | -4.54% |
| Beta Bionics, Inc. (BBNX)vs › | $837.71M | -61.32% | -78.55% | -9174.62% | -9174.62% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $770.68M | -147.38% | -372.93% | -22199.44% | -19748.48% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $847.73M | -560.85% | -63.69% | -31.84% | -21.23% |
Operating Margin
-7.9%
Net Profit Margin
-12.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -13.83% |
| 2026-03-31 | -39.81% |
| 2025-12-31 | -0.33% |
| 2025-09-30 | -0.88% |
| 2025-06-30 | -19.54% |
| 2025-03-31 | -55.51% |
| 2024-12-31 | 4.00% |
| 2024-09-30 | -0.82% |
| 2024-06-30 | -22.47% |
| 2024-03-31 | -57.62% |
| 2023-12-31 | -83.82% |
| 2023-09-30 | 11.76% |
| 2023-06-30 | -76.66% |
| 2023-03-31 | -235.49% |
| 2022-12-31 | 24.21% |
| 2022-09-30 | -459.15% |
| 2022-06-30 | -1066.43% |
| 2022-03-31 | -5998.08% |
| 2021-12-31 | -3521.28% |
| 2021-09-30 | -3715.86% |
| 2021-06-30 | -3441.66% |
| 2021-03-31 | -503.72% |
| 2020-12-31 | -1596.24% |
| 2020-09-30 | -667.45% |
| 2020-06-30 | -1359.26% |
| 2020-03-31 | -1844.44% |
| 2019-12-31 | -879.56% |
| 2019-09-30 | -781.25% |
| 2019-06-30 | -141483.33% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | -32778.82% |
| 2018-09-30 | -14026.74% |
| 2018-06-30 | -74303.33% |
| 2018-03-31 | -733.58% |
| 2017-12-31 | 24.08% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 49.64% |
| 2015-03-31 | -59.53% |
| 2014-12-31 | -62.64% |
| 2014-09-30 | 0.97% |
| 2014-06-30 | 41.07% |
| 2014-03-31 | -35.92% |
| 2013-12-31 | -50.29% |
| 2013-09-30 | -14.17% |
| 2013-06-30 | -12.22% |
| 2013-03-31 | -7.17% |
